诺和诺德一季度财报:销售额增长19%,司美格鲁肽销售额近80亿美元

药事纵横
08 May

2025年5月7日,诺和诺德发布了2025年第一季度财务报告。报告显示,公司销售额同比增长19%(按丹麦克朗计算),达到781亿丹麦克朗(DKK 78.1 billion),按固定汇率计算(CER)增长18%。营业利润同比增长22%(按丹麦克朗计算),达到388亿丹麦克朗(DKK 38.8 billion),按固定汇率计算增长20%。公司业绩的强劲表现主要得益于糖尿病和肥胖症护理业务的持续增长,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10